These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 8033306)

  • 1. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis.
    Singh J; Kulkarni N; Kelloff G; Reddy BS
    Carcinogenesis; 1994 Jul; 15(7):1317-23. PubMed ID: 8033306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate biomarkers of colon cancer: modulation of expression of ras oncogene by chemopreventive agents during azoxymethane induced colon carcinogenesis.
    Singh J; Kelloff G; Reddy BS
    Carcinogenesis; 1993 Apr; 14(4):699-704. PubMed ID: 8472334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chemopreventive agents on posttranslational plasmamembrane association of ras-p21 during chemoprevention of azoxymethane-induced colon carcinogenesis.
    Singh J; Reddy B
    Int J Oncol; 1995 Feb; 6(2):301-6. PubMed ID: 21556537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of alterations in p53 tumor suppressor gene and its association with activation of ras proto-oncogenes during chemoprevention of colon cancer.
    Singh J; Kelloff G; Reddy B
    Int J Oncol; 1997 Mar; 10(3):449-56. PubMed ID: 21533396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis.
    Singh J; Kelloff G; Reddy BS
    Cancer Epidemiol Biomarkers Prev; 1992; 1(5):405-11. PubMed ID: 1305473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the chemopreventive agents piroxicam and D,L-alpha-difluoromethylornithine on intermediate biomarkers of colon carcinogenesis.
    Kulkarni N; Zang E; Kelloff G; Reddy BS
    Carcinogenesis; 1992 Jun; 13(6):995-1000. PubMed ID: 1600622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
    Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
    Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
    Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS
    Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Jan; 57(2):253-8. PubMed ID: 9000564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oltipraz [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] on azoxymethane-induced biochemical changes related to early colon carcinogenesis in male F344 rats.
    Rao CV; Nayini J; Reddy BS
    Proc Soc Exp Biol Med; 1991 May; 197(1):77-84. PubMed ID: 2020672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
    Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
    Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon.
    Morishita Y; Yoshimi N; Kawabata K; Matsunaga K; Sugie S; Tanaka T; Mori H
    Jpn J Cancer Res; 1997 Sep; 88(9):815-20. PubMed ID: 9369928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
    Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
    Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers as intermediate end-points in chemoprevention of colon-cancer - modulation of ras activation by sulindac and phenylhexylisothiocyanate during colon carcinogenesis.
    Singh J; Rao C; Kulkarni N; Simi B; Reddy B
    Int J Oncol; 1994 Nov; 5(5):1009-18. PubMed ID: 21559673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon.
    Li H; Schut HA; Conran P; Kramer PM; Lubet RA; Steele VE; Hawk EE; Kelloff GJ; Pereira MA
    Carcinogenesis; 1999 Mar; 20(3):425-30. PubMed ID: 10190557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
    Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
    Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds.
    Reddy BS; Tokumo K; Kulkarni N; Aligia C; Kelloff G
    Carcinogenesis; 1992 Jun; 13(6):1019-23. PubMed ID: 1600605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.
    Earnest DL; Holubec H; Wali RK; Jolley CS; Bissonette M; Bhattacharyya AK; Roy H; Khare S; Brasitus TA
    Cancer Res; 1994 Oct; 54(19):5071-4. PubMed ID: 7923119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of c-myc, p16 and p27 in rat colon tumors and its reversal by short-term treatment with chemopreventive agents.
    Tao L; Kramer PM; Wang W; Yang S; Lubet RA; Steele VE; Pereira MA
    Carcinogenesis; 2002 Sep; 23(9):1447-54. PubMed ID: 12189186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.